Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV;Syndrome d'hypersensibilité médicamenteuse au ténofovir ou DRESS chez une patiente infectée par le VIH

Medecine et Maladies Infectieuses

Volumn 43, Issue 3, 2013, Pages 134-135

  Bayonne Kombo, E S ^a,b   Gathse, A ^b,c  

^a Hôpital de Talangaï   (Congo)

^b Fondation Congolaise pour la Recherche Médicale Faculté des Sciences de la Santé University Marien Ngouabi   (Congo)

^c Centre Hospitalier et Universitaire de Brazzaville   (Congo)

Author keywords

Antiretroviral; DRESS syndrome; Drug reaction; Tenofovir

Indexed keywords

TENOFOVIR;

DRESS SYNDROME; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER;

ADENINE; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASTHENIA; BENZOXAZINES; DEOXYCYTIDINE; DIDEOXYNUCLEOSIDES; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; FEMALE; FEVER; HIV INFECTIONS; HUMANS; LAMIVUDINE; NEVIRAPINE; ORGANOPHOSPHONATES; REVERSE TRANSCRIPTASE INHIBITORS; SYNDROME;

EID: 84876808705     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2013.01.008     Document Type: Letter

References (7)

1. Descamps V., Ben Saïd B., Sassolas B., et al. Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol 2010, 137:703-708.
2. Begon E., Roujeau J.C. Syndrome d'hypersensibilité médicamenteuse ou DRESS (drug reaction with eosinophilia and systemic symptoms). Ann Dermatol Venereol 2004, 131:293-297.
3. Begaud B. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 1985, 40:111-118.
4. Murphy R.A., Sunpath H., Kuritzkes D.R., Venter F., et al. Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary. J Infect Dis 2007, 196:S449-S456.
5. Santos R.P., Ramilo O., Barton T. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. Pediatr Infect Dis J 2007, 26(11):1053-1056.
6. Lockhart S.M., Rathbuna R.C., Stephen J.R., et al. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases. AIDS 2007, 21(10):1370-1373.
7. Ripamonti D., Maggiolo F., Suter F. Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman. AIDS 2007, 21(8):1059-1060.